Boston Scientific (BSX) Change in Acquisitions & Divestments (2009 - 2021)
Boston Scientific's (BSX) quarterly Change in Acquisitions & Divestments came in at -$23.0 million in Q2 2021, down 160.53% quarter-over-quarter from $38.0 million in Q1 2021.
Powered by 
Analysis
Boston Scientific (BSX) Change in Acquisitions & Divestments (2009 - 2021) Analysis & Trends
Boston Scientific has disclosed Change in Acquisitions & Divestments across 4 years of filings, most recently posting -$23.0 million for Q2 2021.
- In Q2 2021, Change in Acquisitions & Divestments changed N/A year-over-year to -$23.0 million; the TTM figure through Sep 2022 stood at $15.0 million (changed 0.0% YoY), while the FY2015 annual figure was $61.0 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments came in at -$23.0 million for Q2 2021 at Boston Scientific, down from $38.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $38.0 million in Q1 2021 to a low of -$23.0 million in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -23.00 Mn |
| Mar 31, 2021 | 38.00 Mn |
| Sep 30, 2011 | 1.00 Mn |
| Dec 31, 2010 | 3.00 Mn |
| Dec 31, 2009 | 37.00 Mn |
| Sep 30, 2009 | 4.00 Mn |
| Mar 31, 2009 | 50.00 Mn |